Edition:
United States

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

4.86USD
18 Jan 2019
Change (% chg)

$-0.18 (-3.57%)
Prev Close
$5.04
Open
$5.04
Day's High
$5.05
Day's Low
$4.74
Volume
137,924
Avg. Vol
148,472
52-wk High
$14.62
52-wk Low
$3.60

Chart for

About

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. The Company has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR,... (more)

Overall

Beta: --
Market Cap(Mil.): $763.12
Shares Outstanding(Mil.): 93.52
Dividend: --
Yield (%): --

Financials

  ADAP.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -1.00 -- --
ROI: -32.06 8.99 14.48
ROE: -35.60 10.13 15.99

Earnings vs. Estimates